Advancing Pathways for the Development of Innovative Therapies for Children With Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is common enough that most hospital and community-based pediatricians will have to take care of children with some type of IBD. Addressing the needs of children with IBD related to drug development across stakeholders has emerged as a very important medical topic. Watch our webinar recordings to learn from our experts.
- Developing solutions to advance pathways for regulatory approval and labeling of IBD therapies for use in children
- Gaining perspective and exploring solutions through discussions with patients and families, clinicians, pharmaceutical sponsors and regulators
- Identifying gaps in knowledge that impact the development process and explore actionable items to address these gaps
What Attendees Are Saying:
“Very eye-opening presentation. Loved hearing from the patient and family advocates too!”
“Outstanding content and speakers.”
“Fabulous meeting — very relevant and important discussion; scientific based high-quality presentations!”
Watch the Virtual Public Webinar Series Hosted by I-ACT for Children
Perspectives: Patient, Family and Healthcare Providers
Clinical Trial Designs and relevant discussion points from the previous three webinars
This Forum has been supported in part by a grant from the US Food and Drug Administration (award #5Y18FD006297), in addition to educational grants received from Eli Lilly and Company, Janssen Research & Development LLC and the Pharmaceutical Research and Manufacturers of America.